Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

7.51
+0.07000.94%
Volume:255.59K
Turnover:1.90M
Market Cap:761.17M
PE:-7.33
High:7.54
Open:7.41
Low:7.36
Close:7.44
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 31, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 12, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 24, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
Jun 08, 2022

Correspondence

CORRESP [Cover] - Correspondence